NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
BioElectronics Corporation Chairman's Update: Sales Growth, Strategic Progress, and Non-Opioid Pain Management Focus
BioElectronics Corporation reports increased sales and a small profit for 2025, driven by cost controls and targeted advertising campaigns. The company is pursuing clinical trials for reimbursement under the NO PAIN Act and advancing a strategic partnership with Electrome Corporation.
The update informs shareholders about the company's financial performance, strategic initiatives, and progress in expanding market presence for its non-opioid pain management products.
The company reported a small profit for calendar year 2025, achieved through cost control measures including relocating offices and reducing staff.
The company runs targeted advertising campaigns directed at medical professionals (surgeons, pain specialists, chiropractors) and consumer-focused social media ads targeting Generation X consumers seeking non-opioid pain relief.
BioElectronics is seeking a clinical trial partner for RecoveryRx in postoperative settings to support qualification for reimbursement under the federal NO PAIN Act initiative.
The company is pursuing arbitration against a former distributor for breach of contract, working with legal counsel in Singapore and funders in China, and will provide updates as developments occur.
Electrome has placed an initial purchase order, and manufacturing is underway for a commercial launch of BioElectronics' pulsed shortwave therapy products through Electrome's platform, representing an important operational milestone.
Professional advertising targets surgeons, pain specialists, rehabilitation providers, chiropractors, and other healthcare providers. Consumer ads target Generation X individuals with chronic musculoskeletal pain.
Qualifying for reimbursement under the NO PAIN Act could support broader adoption of non-opioid pain management technologies in surgical settings, representing a meaningful long-term opportunity.